Added to YB: 2025-06-23
Pitch date: 2025-06-20
LFCR [bullish]
Lifecore Biomedical, Inc.
+12.09%
current return
Author Info
Alt Capital writes about public equities and credit with a focus on special situations: restructurings, M&A, spinoffs, governance changes, stockholder activism. Primarily small/micro caps. Background in corporate restructuring (~10 years). Based in NYC. Sign up for the newsletter.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$298.2M
Pitch Price
$6.95
Price Target
14.00 (+80%)
Dividend
N/A
EV/EBITDA
-128.16
P/E
-6.25
EV/Sales
3.62
Sector
Life Sciences Tools and Services
Category
turnaround
Lifecore Biomedical - Post Restructuring, Inflecting Financials Over Next 3 Years, Possible Near-term Transaction
LFCR: Pure-play CDMO emerging from 5-year restructuring with new management. Operating at 20% capacity (15% EBITDA margin), targeting 40% utilization within 3 years (25%+ margins, 12%+ revenue CAGR). High industry multiples supported by M&A (Avid 43x, Catalent 23x, Societal 27x). 80% company-estimated change-of-control probability by 2029.
Read full article (8 min)